Telomerase activity in plasma cell dyscrasias

被引:0
|
作者
D Xu
C Zheng
S Bergenbrant
G Holm
M Björkholm
Q Yi
A Gruber
机构
[1] Karolinska Hospital,Department of Medicine, Division of Hematology
[2] University of Arkansas for Medical Sciences,Myeloma and Transplantation Research Center
来源
British Journal of Cancer | 2001年 / 84卷
关键词
hTERT; multiple myeloma; plasma cells; telomerase;
D O I
暂无
中图分类号
学科分类号
摘要
Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and plasma cell leukaemia (PCL). All 5 patients with MGUS exhibited normal levels of telomerase activity in their plasma cells. Elevated telomerase activity was found in the samples from 21/27 patients with MM and 4/4 with PCL. In addition, 4 myeloma cell lines all expressed high levels of telomerase activity. The expression of telomerase reverse transcriptase (hTERT) and telomerase RNA template (hTER) was positively associated with the levels of telomerase activity in MM/PCL. Tankyrase expression was upregulated, concomitant with the induction of hTERT and activation of telomerase in MM/PCL. The present findings indicate that MGUS cells may not be immortalized and that activation of telomerase plays a role in the malignant transformation from MGUS to MM. © 2001 Cancer Research Campaign
引用
收藏
页码:621 / 625
页数:4
相关论文
共 50 条
  • [21] POLYNEUROPATHIES ASSOCIATED WITH PLASMA-CELL DYSCRASIAS
    KELLY, JJ
    SEMINARS IN NEUROLOGY, 1987, 7 (01) : 30 - 39
  • [22] Kidney disease associated with plasma cell dyscrasias
    Heher, Eliot C.
    Goes, Nelson B.
    Spitzer, Thomas R.
    Raje, Noopur S.
    Humphreys, Benjamin D.
    Anderson, Kenneth C.
    Richardson, Paul G.
    BLOOD, 2010, 116 (09) : 1397 - 1404
  • [23] The promise and harms of screening for plasma cell dyscrasias
    Mohyuddin, Ghulam Rehman
    Chakraborty, Rajshekhar
    Scheffer Cliff, Edward R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (06) : 704 - 707
  • [24] Histological and immunomistochemical characteristics of the plasma cell dyscrasias
    Duganovska, Snezana
    Petrusevska, Gordana
    Andonovska, Lolita
    Kunovska, Slavica Kostadinova
    Filipovski, Vanja
    Vasileva, Maja
    VIRCHOWS ARCHIV, 2007, 451 (02) : 354 - 355
  • [25] PLASMA-CELL DYSCRASIAS - A CURRENT PERSPECTIVE
    OSSERMAN, EF
    ACTA HAEMATOLOGICA, 1982, 68 (03) : 167 - 168
  • [26] PLASMA-CELL DYSCRASIAS - CURRENT STATUS
    KYLE, RA
    GREIPP, PA
    CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1988, 8 (02): : 93 - 152
  • [27] Whole blood viscosity in plasma cell dyscrasias
    Uggla, Bertil
    Nilsson, Torbjorn K.
    CLINICAL BIOCHEMISTRY, 2015, 48 (03) : 122 - 124
  • [28] PLASMA-CELL DYSCRASIAS (EXCEPT MYELOMA)
    RENNER, RR
    SMITH, JR
    SEMINARS IN ROENTGENOLOGY, 1974, 9 (03) : 209 - 218
  • [29] FAMILY ASSOCIATION OF PLASMA CELL DYSCRASIAS IGM
    Casanova, Galan Evelin
    Escoda, Teigell Lourdes
    Gimenez, Perez Teresa
    Aguilar, Balta Luiz Andre
    Cano, Alburquerque Paula
    Vallansot, Rolando Omar
    Cervera, Calvo Marta
    Vicent, Castello Ana
    Do Nascimento Ferreira, Janilson
    Talarn, Forcadell Carme
    Aguinaco, Culebras Reyes
    Martin, Batista Silvia
    Araguas, Arasanz Carmen
    Sarra, Escarre Josep
    HAEMATOLOGICA, 2020, 105 : 364 - 364
  • [30] Dealing with Neuropathy in Plasma-Cell Dyscrasias
    Sonneveld, Pieter
    Jongen, Joost L. M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2010, : 423 - 430